These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631 [TBL] [Abstract][Full Text] [Related]
23. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847 [TBL] [Abstract][Full Text] [Related]
24. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805 [TBL] [Abstract][Full Text] [Related]
26. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Tanaka M; Terry RD; Mokhtari GK; Inagaki K; Koyanagi T; Kofidis T; Mochly-Rosen D; Robbins RC Circulation; 2004 Sep; 110(11 Suppl 1):II194-9. PubMed ID: 15364862 [TBL] [Abstract][Full Text] [Related]
27. [Effect of puerarin on ADMA-DDAH system in human umbilical vein endothelial cells cultured with oxidized free radical]. Li JX; Chen J; Deng ZH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1103-6. PubMed ID: 17205823 [TBL] [Abstract][Full Text] [Related]
29. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368 [TBL] [Abstract][Full Text] [Related]
30. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Wang D; Gill PS; Chabrashvili T; Onozato ML; Raggio J; Mendonca M; Dennehy K; Li M; Modlinger P; Leiper J; Vallance P; Adler O; Leone A; Tojo A; Welch WJ; Wilcox CS Circ Res; 2007 Sep; 101(6):627-35. PubMed ID: 17673667 [TBL] [Abstract][Full Text] [Related]
31. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280 [TBL] [Abstract][Full Text] [Related]
32. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice. Desai A; Zhao Y; Warren JS Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093 [TBL] [Abstract][Full Text] [Related]
33. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Yin QF; Fu SH; He P; Xiong Y Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509 [TBL] [Abstract][Full Text] [Related]